NCT00000335View on ClinicalTrials.gov

Activity Monitoring Assessment of Opiate Withdrawal - 4

PHASE2CompletedINTERVENTIONAL
0
Timeline

Start Date

September 30, 1995

Primary Completion Date

March 20, 1996

Study Completion Date

May 20, 1996

Conditions
Opioid-Related Disorders
Interventions
DRUG

Morphine

Trial Locations (1)

20422

Washington DC VA, Washington D.C.

All Listed Sponsors
collaborator

Washington D.C. Veterans Affairs Medical Center

FED

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00000335 - Activity Monitoring Assessment of Opiate Withdrawal - 4 | Biotech Hunter | Biotech Hunter